Janet Celosia
Hospital Utilization for Skin Diseases in Persons Experiencing Homelessness
One in 25 Americans will experience homelessness in their lifetime. Homelessness is an independent risk factor for increased emergency department use, the longer length of hospital stay, and hospital readmission….
Contributions of Early Life Bacterial-Barrier-Immune Interactions in the Path to Atopy
Pediatric atopic dermatitis (AD) is a chronic, costly, and high-morbidity disease. The earliest events that precede disease onset and modulate severity in at-risk infants remain poorly defined. Using novel experimental…
Top 5 Research Advancements in Psoriasis Biology and Therapy
The Dermatology Foundation’s investment in psoriasis researchers and projects is an important part of its history. The clinical observation of the 1980’s that psoriasis responded to the immunosuppression of cyclosporine…
7 Advances in Atopic Dermatitis
While corporate interest in developing targeted agents to treat atopic dermatitis (AD) has been growing rapidly over the past few years, the Dermatology Foundation has a long history of funding…
Dermatology Foundation Awards $2.7 million in Research Funding
Thanks to the support of its physician members and industry supporters during a turbulent year, the Dermatology Foundation (DF) was able to award $2.7 million in research support for 2021….
John E. Bournas Named Executive Director
EVANSTON, Ill. (Sept. 25, 2020) – Elizabeth I. McBurney, MD, Chair of the Board of Trustees and Janet A. Fairley, MD, President of the Dermatology Foundation are pleased to announce…
2020 Research Award Recipients
The Board of Trustees is pleased to present the 59 recipients of the 2020 DF research awards. Charles and Daneen Stiefel Scholar Award in Skin Cancer Brian C. Capell, M.D.,…